BioMarin Pharmaceutical | BMRN - 영업 이익





영업 이익 변화 날짜
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
Bayer EUR 129M 698M 2026-09
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
Incyte USD -707.47M 1.41B 2026-09
Insmed USD -81.83M 19.48M 2026-09
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
Moderna USD 130M 945M 2026-09
Neurocrine Biosciences USD 343M 123.1M 2026-09
PTC Therapeutics USD 148.98M 103.09M 2026-06
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 2.38B 115M 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
United Therapeutics USD 241.3M 89.5M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09